GEM
ABBV icon

Global Endowment Management’s AbbVie ABBV Stock Holding History

Global Endowment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,817
Closed -$302K – 108
2020
Q4 		$302K Sell
2,817
-550
-16% -$52.9K 0.02% 103
2020
Q3 		$295K Hold
3,367
– – 0.02% 109
2020
Q2 		$331K Hold
3,367
– – 0.02% 88
2020
Q1 		$257K Hold
3,367
– – 0.02% 88
2019
Q4 		$298K Buy
+3,367
New +$280K 0.02% 91

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Global Endowment Management's ABBV Position: Q1 2021 in Review

Global Endowment Management sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 2,817 shares — an estimated $302K sold.

Global Endowment Management first reported a position in ABBV in Q4 2019 and held it in 5 quarters. The position peaked at $331K in Q2 2020. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Global Endowment Management reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Global Endowment Management sold 2,817 AbbVie shares in Q1 2021, an estimated $302K.
  • Global Endowment Management first reported a position in AbbVie in Q4 2019 and held it in 5 quarters.
  • Global Endowment Management's AbbVie position peaked at $331K in Q2 2020.
  • 2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Global Endowment Management's 13F filing for Q1 2021, filed 17 May 2021.